Rosiglitazone Promotes Bone Marrow Adipogenesis to Impair Myelopoiesis under Stress

OBJECTIVE: The therapeutic use of thiazolidinediones (TZDs) causes unwanted hematological side effects, although the underlying mechanisms of these effects are poorly understood. This study tests the hypothesis that rosiglitazone impairs the maintenance and differentiation of hematopoietic stem/prog...

Full description

Saved in:
Bibliographic Details
Published in:PLoS One
Main Authors: Lu, Wenyi, Wang, Weimin, Wang, Shujuan, Feng, Yonghuai, Liu, Kaiyan
Format: Artigo
Language:Inglês
Published: Public Library of Science 2016
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4760757/
https://ncbi.nlm.nih.gov/pubmed/26895498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0149543
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items